This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Apple Analysts Weigh In on Jobs' Health

NEW YORK ( TheStreet) -- Analysts offered cautions and assurances as Apple gets ready to veer into the unknown again without its visionary leader Steve Jobs.

Investors who have pushed the stock to record-high levels in the past month took a bit of caution Tuesday in the wake of the announcement that Jobs was ill and taking another medical leave. Apple shares were down 4% Tuesday.

Though the news was awful for those that see Jobs as the key to Apple's ongoing success, analysts took the announcement in stride. No one called it a great day for Apple, nor did anyone wave a red flag in crisis.
Steve Jobs
Apple CEO Steve Jobs

"Mr. Jobs' health wellness profile may not be what investors prefer, but we point out that Apple's strategic initiatives have not been derailed by past medical leaves," JP Morgan analyst Mark Moskowitz wrote in a research note Tuesday.

Jobs' illness comes at a time when the Apple machinery seems to be humming along at a record clip; his absence will offer a test of just how durable the company's momentum can be. Apple reports December quarter earnings after the bell today -- TheStreet will live-blog the earnings call -- and the company is expected to shoot well past Wall Street targets.

Still, it's Apple's future that investors are primarily focused on and no single person is seen as instrumental to forging that path as Steve Jobs. As Apple legend holds, Jobs' influence is weaved throughout the company and his connection to Apple consumers is astonishingly tight.

"Jobs and his team have made Apple become the primal force in shaping consumers' technology-driven 'way of life,'" Moskowitz wrote.

Apple's succession plan, should Jobs not return, is well understood as COO Tim Cook steps in again in his boss' absence.

"Tim Cook is a proven executive who can handle the pressure and knows how to run the inner workings of Apple in Steve's shadow. We believe Apple is in capable hands," Barclay's analyst Ben Reitzes wrote Tuesday.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.24 -0.41%
FB $117.81 -0.21%
GOOG $701.43 0.82%
TSLA $211.53 -4.96%
YHOO $36.94 2.61%


Chart of I:DJI
DOW 17,660.71 +9.45 0.05%
S&P 500 2,050.63 -0.49 -0.02%
NASDAQ 4,717.0940 -8.5450 -0.18%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs